"News ReleaseJuly 31, 2020JCR Pharmaceuticals Co., Ltd.TranslationNotice regarding Capital Expendituresto Increase Production Capacity at the Seishin PlantJCR Pharmaceuticals Co., Ltd. (TSE 4552: Chairman and President Shin Ashida, "JCR") announced today about capital expenditures to expand the manufacturing area to increase production capacity for TEMCELL® HS Inj.Seishin Plant, one of JCR's production bases, manufactures TEMCELL® HS Inj., a regenerative medical product, and medical devices. Medical institutions have highly rated TEMCELL® HS Inj. since its launch in 2016 and JCR has received orders far in excess of its initial forecasts.JCR has addressed this increased demand by moving ahead with efforts to increase production, including boosted capital expenditures up until now, and has now decided to expand the Seishin Plant's manufacturing area to further expand its production capacity.This expansion will raise the production capacity for TEMCELL® HS Inj. by about 30% over current levels, ensure an appropriate inventory and enable sufficient supply to meet the market's robust demand. The concept, specifications studies, contractor selection and other matters related to this expansion have already been completed.Costs foreseen in this expansion are mainly expected to arise in the future and are expected to have only a negligible effect on JCR's consolidated financial results for the fiscal year ending March 31, 2021.As a specialty pharma engaged in the development of pharmaceutical products for rare diseases, JCR will continue to strengthen business activities in the future and strive to contribute to the treatment of as many patients as possible."
If it is only an extra 2 patients, it would mean 30% more patients on 7 patients is about 2.
If they are treating 200 patients it's an extra 60.
Can you show the press release please?
Thanks
- Forums
- ASX - By Stock
- MSB Trading 2021 - paradigm shift
"News ReleaseJuly 31, 2020JCR Pharmaceuticals Co.,...
-
- There are more pages in this discussion • 2,276 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.045(4.52%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.5¢ | $2.669M | 2.769M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.5¢ | 13191 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2053 | 0.950 |
5 | 69192 | 0.945 |
16 | 152239 | 0.940 |
10 | 194253 | 0.935 |
9 | 112676 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.955 | 13191 | 2 |
0.960 | 60726 | 4 |
0.965 | 33726 | 1 |
0.970 | 53885 | 3 |
0.975 | 54219 | 6 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online